05/12/2022
4:15 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2022
4:29 PM | Supernus Pharmaceuticals (Filer)
| Form NT 10-Q
| |
05/09/2022
4:22 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2022
3:42 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/13/2022
3:18 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2021
4:17 PM | DEC TIMOTHY C (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2021
4:13 PM | DEC TIMOTHY C (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/06/2021
11:52 AM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/04/2021
4:28 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2021
3:36 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
06/25/2021
11:30 AM | Supernus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/25/2021
7:12 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2021
8:04 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/26/2021
3:35 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2021
3:46 PM | Supernus Pharmaceuticals (Filer)
| Form DEFA14A
| |
05/24/2021
3:44 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2021
3:58 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2021
1:34 PM | Supernus Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/30/2021
1:31 PM | Supernus Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/14/2021
7:24 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/30/2021
5:23 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2021
3:30 PM | Supernus Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2021
4:27 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2021
11:48 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2021
5:55 PM | Kelly James Patrick (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
5:54 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
5:54 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
5:53 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
5:51 PM | Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
5:49 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
5:49 PM | SIEBERT JOHN M (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
5:49 PM | Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
5:49 PM | Banyai William (Reporting)
Supernus Pharmaceuticals (Issuer)
Twist Bioscience Corp (Issuer)
Twist Bioscience Corp (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
5:48 PM | GEMAYEL GEORGES (Reporting)
GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
5:48 PM | Supernus Pharmaceuticals (Issuer)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
5:47 PM | Hudson Frederick M. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
5:46 PM | NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2021
5:46 PM | Barlow Carrolee (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2021
4:14 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2021
3:50 PM | BlackRock Inc. (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G
| |
01/04/2021
6:59 PM | Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/22/2020
4:49 PM | Schwabe Stefan K.F. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2020
7:20 PM | Schwabe Stefan K.F. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2020
4:27 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/10/2020
3:19 PM | PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2020
4:43 PM | PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2020
2:31 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/15/2020
5:04 PM | PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2020
11:03 AM | Kelly James Patrick (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2020
11:00 AM | Kelly James Patrick (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2020
11:26 AM | Supernus Pharmaceuticals (Filer)
Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2020
3:31 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2020
4:12 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2020
3:11 PM | PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2020
3:12 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K/A
| |
08/17/2020
3:52 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2020
3:35 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2020
3:13 PM | Supernus Pharmaceuticals (Filer)
| Form NT 10-Q
| |
07/28/2020
3:35 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2020
2:18 PM | Supernus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/15/2020
4:13 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2020
7:07 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/27/2020
3:33 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2020
5:59 PM | PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2020
1:14 PM | Supernus Pharmaceuticals (Filer)
| Form NT 10-Q
| |
05/11/2020
5:42 PM | PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2020
3:52 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2020
11:00 AM | Supernus Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/24/2020
8:27 AM | Supernus Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/24/2020
8:26 AM | Supernus Pharmaceuticals (Filer)
| Form DEF 14A
| |
03/23/2020
7:36 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2020
4:13 PM | ARMISTICE CAPITAL, LLC (Filed by)
Supernus Pharmaceuticals (Subject)
| Form SC 13G
| |
02/28/2020
12:05 PM | Supernus Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2020
5:51 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2020
5:40 PM | Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/25/2020
5:33 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2020
5:31 PM | Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/25/2020
4:59 PM | NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2020
3:36 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2020
10:07 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2019
3:02 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2019
3:12 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2019
1:59 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2019
4:14 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2019
3:04 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2019
3:29 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2019
4:27 PM | Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2019
11:25 AM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2019
10:02 AM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2019
3:57 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2019
4:28 PM | PATRICK GREGORY S (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2019
4:20 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2019
7:06 PM | SIEBERT JOHN M (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
3:29 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2019
3:18 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2019
2:38 PM | Supernus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2019
4:30 PM | Supernus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2019
3:12 PM | Supernus Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/29/2019
2:43 PM | SIEBERT JOHN M (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2019
4:33 PM | Matushansky Igor (Reporting)
Supernus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
